The Europe AI In Medical Imaging Market would witness market growth of 31.7% CAGR during the forecast period (2023-2030).
The Germany market dominated the Europe AI In Medical Imaging Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $625.7 million by 2030. The UK market is exhibiting a CAGR of 30.5% during (2023 - 2030). Additionally, The France market would experience a CAGR of 32.8% during (2023 - 2030).
As the prevalence of NCDs such as cardiovascular diseases, cancer, diabetes, and respiratory conditions rises, there is a corresponding increase in the demand for diagnostic imaging services. AI-powered medical imaging technologies play a crucial role in early detection, diagnosis, and monitoring of NCDs, driving the adoption of these advanced solutions in healthcare settings.
AI algorithms reconstruct low-quality or noisy images, remove artifacts, and enhance image resolution to improve radiologists’ and clinicians’ visualization and interpretation. AI-driven image enhancement techniques enable the creation of 3D reconstructions, virtual simulations, and augmented reality overlays for surgical planning, image-guided interventions, and medical education.
The growing prevalence of cardiovascular disease places a considerable burden on healthcare systems across Europe. According to the Eurostat, diseases of the circulatory system are the main cause of death in the EU, responsible for almost one-third (32.7 %) of all deaths in 2020. The standardized death rate for cerebrovascular diseases in 2020 in Bulgaria (which had the highest rate among the EU Member States) was 8.4 times higher than in France (which had the lowest rate). Hence, the rising prevalence of cardiovascular disease in the region propels the market’s growth.
Based on Technology, the market is segmented into Deep Learning, Natural Language Processing (NLP), and Others. Based on Modality, the market is segmented into CT Scan, MRI, Ultrasound, X-rays, and Nuclear Imaging. Based on End-use, the market is segmented into Hospitals, Diagnostic Imaging Centers, and Others. Based on Application, the market is segmented into Neurology, Breast Screening, Cardiology, Respiratory & Pulmonary, Orthopedics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe AI In Medical Imaging Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $625.7 million by 2030. The UK market is exhibiting a CAGR of 30.5% during (2023 - 2030). Additionally, The France market would experience a CAGR of 32.8% during (2023 - 2030).
As the prevalence of NCDs such as cardiovascular diseases, cancer, diabetes, and respiratory conditions rises, there is a corresponding increase in the demand for diagnostic imaging services. AI-powered medical imaging technologies play a crucial role in early detection, diagnosis, and monitoring of NCDs, driving the adoption of these advanced solutions in healthcare settings.
AI algorithms reconstruct low-quality or noisy images, remove artifacts, and enhance image resolution to improve radiologists’ and clinicians’ visualization and interpretation. AI-driven image enhancement techniques enable the creation of 3D reconstructions, virtual simulations, and augmented reality overlays for surgical planning, image-guided interventions, and medical education.
The growing prevalence of cardiovascular disease places a considerable burden on healthcare systems across Europe. According to the Eurostat, diseases of the circulatory system are the main cause of death in the EU, responsible for almost one-third (32.7 %) of all deaths in 2020. The standardized death rate for cerebrovascular diseases in 2020 in Bulgaria (which had the highest rate among the EU Member States) was 8.4 times higher than in France (which had the lowest rate). Hence, the rising prevalence of cardiovascular disease in the region propels the market’s growth.
Based on Technology, the market is segmented into Deep Learning, Natural Language Processing (NLP), and Others. Based on Modality, the market is segmented into CT Scan, MRI, Ultrasound, X-rays, and Nuclear Imaging. Based on End-use, the market is segmented into Hospitals, Diagnostic Imaging Centers, and Others. Based on Application, the market is segmented into Neurology, Breast Screening, Cardiology, Respiratory & Pulmonary, Orthopedics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Fujifilm Holdings Corporation
- Agfa-Gevaert NV
- Microsoft Corporation
- Google LLC (Alphabet Inc.)
- Intel Corporation
- NVIDIA Corporation
- Zebra Technologies Corporation
Market Report Segmentation
By Technology- Deep Learning
- Natural Language Processing (NLP)
- Others
- CT Scan
- MRI
- Ultrasound
- X-rays
- Nuclear Imaging
- Hospitals
- Diagnostic Imaging Centers
- Others
- Neurology
- Breast Screening
- Cardiology
- Respiratory & Pulmonary
- Orthopedics
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Europe AI In Medical Imaging Market by Technology
Chapter 6. Europe AI In Medical Imaging Market by Modality
Chapter 7. Europe AI In Medical Imaging Market by End-use
Chapter 8. Europe AI In Medical Imaging Market by Application
Chapter 9. Europe AI In Medical Imaging Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Fujifilm Holdings Corporation
- Agfa-Gevaert NV
- Microsoft Corporation
- Google LLC (Alphabet Inc.)
- Intel Corporation
- NVIDIA Corporation
- Zebra Technologies Corporation
Methodology
LOADING...
